In Vivo briefly summarizes the technologies of these recently founded companies: Afmedica Inc., BARRx Inc., Bioline Therapeutics, Deciphera Pharmaceuticals Inc., Resonant Medical Inc. and Spliceomix Inc.
259 East Michigan Avenue
Suite 409
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.
While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.
UK biotech targets the root cause of metabolic disease while preserving muscle mass in a crowded obesity market.
